D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$667M |
| 2 |
NVIDIA
NVDA
|
+$584M |
| 3 |
ConocoPhillips
COP
|
+$432M |
| 4 |
Amazon
AMZN
|
+$418M |
| 5 |
Johnson & Johnson
JNJ
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$836M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
Apple
AAPL
|
+$453M |
| 4 |
CELG
Celgene Corp
CELG
|
+$349M |
| 5 |
Pfizer
PFE
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.58% |
| 2 | Consumer Discretionary | 13.65% |
| 3 | Healthcare | 12.98% |
| 4 | Industrials | 7.3% |
| 5 | Financials | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Tronox
TROX
$995M
| $534K | ﹤0.01% |
41,766
+27,328
| +189% | +$335K |
|
|
UCFC
3002
DELISTED
United Community Financial Corp
UCFC
| $533K | ﹤0.01% |
55,719
+42,674
| +327% | +$398K |
|
3003
CALL
Cognizant
CTSH
$21.5B
| $532K | ﹤0.01% |
8,400
-32,000
| -79% | -$2.1M |
|
3004
Rafael Holdings
RFL
$111M
| $532K | ﹤0.01% |
18,777
-975
| -5% | -$16.8K |
|
3005
PUT
Range Resources
RRC
$9.11B
| $532K | ﹤0.01% |
76,200
-47,400
| -38% | -$412K |
|
|
GBT
3006
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $531K | ﹤0.01% |
10,100
| – | – |
|
3007
Camtek
CAMT
$6.9B
| $527K | ﹤0.01% |
62,427
-15,218
| -20% | -$140K |
|
|
ZEPP
3008
Zepp Health
ZEPP
$71.9M
| $527K | ﹤0.01% |
+13,183
| New | +$550K |
|
|
TBCH
3009
Turtle Beach Corp
TBCH
$239M
| $527K | ﹤0.01% |
+45,586
| New | +$483K |
|
3010
PUT
Armstrong World Industries
AWI
$6.86B
| $525K | ﹤0.01% |
+5,400
| New | +$483K |
|
|
MANT
3011
DELISTED
Mantech International Corp
MANT
| $523K | ﹤0.01% |
7,939
-8,249
| -51% | -$501K |
|
|
FPRX
3012
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $522K | ﹤0.01% |
86,646
+71,703
| +480% | +$686K |
|
|
STI
3013
CALL
DELISTED
SunTrust Banks, Inc.
STI
| $522K | ﹤0.01% |
8,300
| – | – |
|
3014
Zai Lab
ZLAB
$2.17B
| $521K | ﹤0.01% |
+14,933
| New | +$440K |
|
3015
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
| $520K | ﹤0.01% |
+16,336
| New | +$523K |
|
3016
Fresenius Medical Care
FMS
$13.2B
| $518K | ﹤0.01% |
13,184
-826
| -6% | -$32.7K |
|
3017
Royal Gold
RGLD
$17.1B
| $518K | ﹤0.01% |
5,055
+1,403
| +38% | +$126K |
|
|
CXO
3018
CALL
DELISTED
CONCHO RESOURCES INC.
CXO
| $516K | ﹤0.01% |
5,000
-15,000
| -75% | -$1.62M |
|
3019
BancFirst
BANF
$3.92B
| $515K | ﹤0.01% |
9,245
+127
| +1% | +$7.05K |
|
3020
Nucor
NUE
$56.4B
| $515K | ﹤0.01% |
+9,344
| New | +$513K |
|
|
ESPR
3021
DELISTED
Esperion Therapeutics
ESPR
| $514K | ﹤0.01% |
+11,034
| New | +$518K |
|
3022
CALL
NetEase
NTES
$76.5B
| $512K | ﹤0.01% |
10,000
-56,000
| -85% | -$2.97M |
|
3023
SITE Centers
SITC
$230M
| $512K | ﹤0.01% |
+49,583
| New | +$520K |
|
3024
Darden Restaurants
DRI
$22.5B
| $511K | ﹤0.01% |
4,200
-145,396
| -97% | -$17.3M |
|
3025
PUT
Simon Property Group
SPG
$74.5B
| $511K | ﹤0.01% |
3,200
+200
| +7% | +$34.4K |
|
Similar funds
D.E. Shaw & Co's Q2 2019 Portfolio in Review
As of Q2 2019, D.E. Shaw & Co held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
D.E. Shaw & Co's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
- D.E. Shaw & Co added most to Alibaba in Q2 2019, an estimated $667M increase.
- D.E. Shaw & Co's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
- D.E. Shaw & Co's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
- D.E. Shaw & Co opened 499 new positions and closed 416 in Q2 2019.
- D.E. Shaw & Co's portfolio value rose 3.6% quarter-over-quarter to $80.2B.
Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.